Pharmafile Logo
Pharmafocus logo
Advanced Search
gw_pharma

FDA advisory committee sets GW Pharma up for approval

April 20, 2018
Medical Communications, Sales and Marketing Epidiolex, GW Pharma, biotech, drugs, pharma, pharmaceutical

After the FDA advisory committee unanimously recommended GW Pharma’s Epidiolex for approval, the chances of it not receiving the nod …

News

Allergan out but Takeda sticks to guns on Shire

April 20, 2018
Medical Communications, Sales and Marketing Allergan, Shire, Takeda, biotech, drugs, pharma, pharmaceutical

Allergan performed an odd about-turn after initially declaring its interest in pursuing a deal for Shire, before reneging on that …

News
shutterstock_244903099

The UK’s Royalties withholding tax consultation: Pushing extraterritorial boundaries

April 19, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Norton Rose Fulbright, feature, pharma, tax consultation

Norton Rose Fulbright’s Dominic Stuttaford, James Baillieu and Susie Brain discuss the implications regarding the recent reforms to cross-border royalties.The …

Feature
astrazeneca_building_white

AZ’s Tagrisso gets FDA nod in first-line EGFR-mutated lung cancer

April 19, 2018
Sales and Marketing AstraZeneca, Cancer, EGFR-TKIs, NSCLC, Tagrisso, lung cancer, pharma

AstraZeneca has announced that its epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) Tagrisso (osimertinib) has received approval from …

News
8384110298_da510e0347_c

BenevolentAI financing round takes valuation to $2bn+

April 19, 2018
Medical Communications BenevolentAI, biotech, drugs, pharma, pharmaceutical

BenevolentAI, a London based drug discovery biotech, has revealed that a $115 million financing round now sees the company valued …

News
john_tsai

Novartis snatches Amgen and BMS veteran for CMO and Drug Development Head

April 19, 2018
Medical Communications Amgen, BMS, Bristol-Myers Squibb, Novartis, appointment, pharma

Dr John Tsai has been welcomed to the fold as Novartis’ new Head of Global Development and Chief Medical Officer, …

News
merck_kgaa_pyramid_use_with_credit

Merck KGaA finds consumer health buyer in P&G for €3.4bn

April 19, 2018
Sales and Marketing Merck KGaA, P&G, Pfizer, biotech, drugs, pharma, pharmaceutical

Merck KGaA has successfully found a buyer for its healthcare unit, after Proctor & Gamble announced that it was prepared …

News
brexit_flag_0

EMA initiates divorce process from the UK’s MHRA

April 19, 2018
Medical Communications EMA, UK government, biotech, brexit, drugs, pharma, pharmaceutical

The first stage of separation for the EMA from the UK came with the decision to relocate its headquarters to …

News
iannone

Immunomedics’ whirlwind in the C-suite continues

April 18, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Immunomedics hasn’t had the most straight forward year, its $2 billion deal with Seattle Genetics was scuppered by activist investors, …

Appointment
bill_chin_headshot

Frequency Therapeutics hires industry vet

April 18, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Frequency Therapeutics is a biotech with big ideas and it has made a big appointment to back up those ideas, …

Appointment

BMS’ Opdivo+Yervoy combo secures FDA approval in kidney cancer

April 18, 2018
Research and Development, Sales and Marketing BMS, Bristol Myers Swuibb, Cancer, FDA, Yervoy, carcinoma, opdivo, pharma

The FDA has announced its approval of a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), both products from Bristol Myers …

News
epi-pen_1_3

EpiPen shortage hits UK and Canada hard, but not US

April 18, 2018
Research and Development, Sales and Marketing Mylan, Pfizer, biotech, drugs, epipen, pharma, pharmaceutical

Manufacturing issues at the single Pfizer plant that produces the EpiPen epinephrine injector has caused serious shortages in the UK …

News
amgen_flag

Amgen and Novartis’ Aimovig shines in migraine at Phase 3

April 18, 2018
Research and Development Aimovig, Amgen, Novartis, migraine, pharma

Amgen has lifted the curtain on complete Phase 3 data for its calcitonin gene-related peptide receptor (CGRP) inhibitor Aimovig (erenumab) in …

News
jerome_contamine_770x510

Sanofi CFO set to step down this year

April 18, 2018
Medical Communications, Research and Development Sanofi, biotech, cfo, drugs, pharma, pharmaceutical

After a busy start to the year, with a number of acquisitions and a few divestments, Sanofi’s Chief Financial Officer, …

News
gw_pharma

All indications point to approval for cannabis-based therapy

April 17, 2018
Research and Development, Sales and Marketing FDA, GW Pharma, biotech, drugs, pharma, pharmaceutical

GW Pharma are inching step by step towards a likely approval with the FDA, after it received a strong recommendation …

News
novartis_outside_1

Novartis to invest $100m in new malaria treatments

April 17, 2018
Manufacturing and Production, Research and Development Novartis, WHO, malaria, pharma

Novartis has revealed it is to invest $100 million into the research and development of new treatments for malaria over …

News

FDA flip-flops on Alkermes’ drug application

April 17, 2018
Manufacturing and Production, Sales and Marketing Alkermes, FDA, biotech, drugs, pharma, pharmaceutical

Two weeks ago, it looked like the hopes for Alkermes’ ALKS 5461 receiving approval would rely on returning to the …

News
amazon_-_image_silus_grok_-_flickr

Amazon puts selling pharmaceuticals plan on back-burner

April 17, 2018
Manufacturing and Production, Sales and Marketing amazon, biotech, drugs, pharma, pharmaceutical, pharmacy

Last year buzz about Amazon entering the pharmaceutical distribution market steadily grew after it obtained pharmacy licenses in a small …

News
merckwindow_web

Keytruda success continues, beating Opdivo in lung cancer survival

April 17, 2018
Manufacturing and Production, Research and Development Cancer, MSD, NSCLC, keytruda, lung cancer, pharma

Not content with revealing two strong waves of data on its flagship immunotherapy Keytruda (pembrolizumab) over the past weeks, MSD …

News
bill_chin_headshot

Frequency Therapeutics hires industry vet

April 16, 2018
Manufacturing and Production, Medical Communications Frequency Therapeutics, biotech, drugs, pharma, pharmaceutical

Frequency Therapeutics is a biotech with big ideas and it has made a big appointment to back up those ideas, …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026